| Application no. and date | 14191582.7 (espacenet) (Federated) (European Patent Register), 20061024 | | Patent/reg. no. and date | DK/EP 2848258, 20171213 | | Publication date | 20150318 | | Priority no. and date | US 730435 P, 20051026, US 742125 P, 20051202 | | EP pub. no. and date |
EP 2848258 20150318 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/156544 | | Inventor | GRAM, Hermann, Am Bischofsacker 20
79576 Weil, DE,
WRIGHT, Timothy, 471 Puritan Road
Swampscott, MA 01907, US,
MUNDEL, Trevor, 49 Hartwell Road
Carlisle, MA 01741, US,
LOWE, Phil, Novartis Pharma AG
Postfach
4002 Basel, CH,
Jung, Thomas, Weinbergstrasse 40
6300 Zug, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 19/02 (2006.01) , A61P 37/00 (2006.01) , C07K 16/24 (2006.01) | | Title | Behandling af familiær middelhavsfeber med anti-IL-1beta-antistoffer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2018 00024 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
